Skip to NavigationSkip to content

News

0
Gilead's Biktarvy proves non-inferior to standard care for HIV in Black and African American patients
The findings supported the non-inferiority of Biktarvy to a standard regimen of two nucleoside reverse transcriptase inhibitors (NRTIs) and a third...
0
The European Medicines Agency recommends 10 medicines for approval in October meeting
The EMA has recommended marketing authorisation for ten medicines and has also suggested ten label extensions.
0
Patient dies on AstraZeneca COVID-19 vaccine trial, but didn’t receive vaccine dose
The University of Oxford and AstraZeneca say they will continue their coronavirus vaccine clinical trials after a volunteer had died while on the...
0
Purdue Pharma pleads guilty to opioid charges in $8bn settlement with US Department of Justice
As part of the deal, the company will admit that it misled the Drug Enforcement Agency (DEA) through falsifying its drug diversion programme by...
>> More News Stories

Features

Oncology research in the age of COVID-19

Matt Fellows investigates the new challenges facing the oncology space and explores the strategies that can carry it through the disruptive...

>> More Features
>> More News Stories